Press Releases Filter Filter Results Year 2024 (1) 2023 (5) 2022 (23) 2021 (20) 2020 (38) 2019 (36) 2018 (23) 2017 (25) 2016 (20) 2015 (25) 2014 (26) 2013 (31) 2012 (35) November 3, 2021 Impella® Advances to Higher Level of Recommendation in Newest ESC Guidelines November 1, 2021 TCT 2021 to Highlight Improved Patient Outcomes with Impella’s Small, Smart and Connected Technology October 28, 2021 Abiomed Announces Q2 FY 2022 Revenue of $248 Million, Up 18% Year Over Year October 7, 2021 Abiomed Second Quarter Fiscal 2022 Earnings and Conference Call Notification August 18, 2021 FDA Grants Breakthrough Device Designation to Impella ECP, the World’s Smallest Heart Pump August 4, 2021 Abiomed Announces Record Revenue of $253 Million, Up 53% Year Over Year July 15, 2021 Abiomed First Quarter Fiscal 2022 Earnings and Conference Call Notification June 29, 2021 FDA Grants Highest Level of Approval to the Next Generation of Impella RP to Treat Right Heart Failure June 1, 2021 Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients April 29, 2021 Abiomed Announces Record Revenue of $241 Million, up 17% Year Over Year, With 26.0% Operating Margin April 28, 2021 Final Results from the National Cardiogenic Shock Initiative (NCSI) Study Demonstrate the Benefit of Early Cardiac Unloading with Impella® April 28, 2021 Dr. Paula A. Johnson Joins Abiomed Board of Directors April 15, 2021 First Patient Enrolled in PROTECT IV Randomized Controlled Trial of Impella® April 8, 2021 Abiomed Fourth Quarter Fiscal 2021 Earnings and Conference Call Notification February 17, 2021 Abiomed to Present at Upcoming Investor Conferences … 2 3 4 5 …